Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$3.04 +0.10 (+3.32%)
As of: Aug 21, 2026 · 3:59 PM EDT

Scinai Immunotherapeutics (SCNI) Receivables - Other (2020 - 2026)

Scinai Immunotherapeutics (SCNI) posted Receivables - Other of $350.0 million for Q1 2026, up 105.88% sequentially from $170.0 million in Q4 2025.

Scinai Immunotherapeutics (SCNI) Receivables - Other (2020 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Receivables - Other for 7 years, with the latest figure at $350.0 million in Q1 2026.

  • Quarterly Receivables - Other changed N/A year-over-year to $350.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350.0 million (changed N/A YoY) and the FY2025 annual result came in at $170.0 million, up 79712.21% from the prior year.
  • Receivables - Other climbed to $350.0 million in Q1 2026 per SCNI's latest filing, from $170.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $350.0 million in Q1 2026 and troughed at -$123000.0 in Q1 2022.
  • A 5-year average of $34.8 million and a median of $228000.0 in 2023 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2022 and 2025: Receivables - Other plunged 52.45% in 2022, then jumped 79712.21% in 2025.
  • Over 5 years, Receivables - Other stood at $155000.0 in 2022, then jumped by 181.94% to $437000.0 in 2023, then tumbled by 51.26% to $213000.0 in 2024, then surged by 79712.21% to $170.0 million in 2025, then jumped by 105.88% to $350.0 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods registered $350.0 million, $170.0 million, and $236000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Scinai Immunotherapeutics 11.72 Mn -3.10 Bn -1.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 350.00 Mn
Mar 31, 2026 350.00 Mn
Dec 31, 2025 170.00 Mn
Dec 31, 2025 170.00 Mn
Jun 30, 2025 236,000.00
Jun 30, 2025 236,000.00
Dec 31, 2024 213,000.00
Dec 31, 2024 213,000.00
Sep 30, 2024 328,000.00
Sep 30, 2024 328,000.00
Jun 30, 2024 324,000.00
Jun 30, 2024 324,000.00
Mar 31, 2024 288,000.00
Mar 31, 2024 288,000.00
Dec 31, 2023 437,000.00
Dec 31, 2023 437,000.00
Sep 30, 2023 228,000.00
Sep 30, 2023 228,000.00
Jun 30, 2023 138,000.00
Jun 30, 2023 138,000.00